Labcorp Drug Development - Company Profile
Powered by 
All the data and insights you need on Labcorp Drug Development in one report.
$295
- Save hours of research time and resources with
our up-to-date Labcorp Drug Development Strategy Report
- Understand Labcorp Drug Development position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Labcorp Drug Development Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Labcorp Drug Development Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 27 Jul 2021 | Lorem |
| Ardan seeks CRO for Phase I oncology basket trial for 1Q22 start; to close USD 8m Series A in December, CEO says | 18 Feb 2021 | Sean Rai-Roche |
| Golden Biotechnology engages Covance for Phase II COVID-19 study; open to financial advisor pitches for USD 60m raise for COVID-19 plans, CEO says | 17 Sep 2020 | Manasi Vaidya |
| Immutep engages SMS Oncology for possible pivotal Phase II metastatic breast cancer trial with eftilagimod alpha, Covance for NSCLC and head and neck cancer study, CEO says | 10 May 2019 | Manasi Vaidya |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer